Nasopharyngeal carcinoma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(10 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Nasopharyngeal carcinoma}}
{{Nasopharyngeal carcinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}}{{Homa}}{{Faizan}}
 
==Overview==
==Overview==
Biopsy may be helpful in the diagnosis of nasopharyngeal carcinoma.
Nasopharyngoscopy may be helpful in the [[diagnosis]] of nasopharyngeal carcinoma. It is used for assessment of [[tumor]] extension, determination of [[mucosal]] surface involvement and [[biopsy]] of the primary [[tumor]]. [[Fine needle aspiration]] ([[FNA]]) for [[biopsy]] and [[histopathological]] [[analysis]] is used for [[diagnosis]] of nasopharyngeal carcinoma.


==Other Diagnostic Studies==
==Other Diagnostic Studies==
Fine needle aspiration (FNA) and biopsy may be helpful in the diagnosis of nasopharyngeal carcinoma.
 
'''<big>Nasopharyngoscopy</big>'''
 
Nasopharyngoscopy may be helpful in the [[diagnosis]] of nasopharyngeal carcinoma. It is used for:<ref>{{Cite journal
| author = [[Muhyi Al-Sarraf]] & [[Maryada S. Reddy]]
| title = Nasopharyngeal carcinoma
| journal = [[Current treatment options in oncology]]
| volume = 3
| issue = 1
| pages = 21–32
| year = 2002
| month = February
| pmid = 12057084
}}</ref><ref name="KamranRiaz2015">{{cite journal|last1=Kamran|first1=Sophia C.|last2=Riaz|first2=Nadeem|last3=Lee|first3=Nancy|title=Nasopharyngeal Carcinoma|journal=Surgical Oncology Clinics of North America|volume=24|issue=3|year=2015|pages=547–561|issn=10553207|doi=10.1016/j.soc.2015.03.008}}</ref><ref name="WeiSham2005">{{cite journal|last1=Wei|first1=William I|last2=Sham|first2=Jonathan ST|title=Nasopharyngeal carcinoma|journal=The Lancet|volume=365|issue=9476|year=2005|pages=2041–2054|issn=01406736|doi=10.1016/S0140-6736(05)66698-6}}</ref>
 
*Assessment of [[tumor]] extension
*Determination of [[mucosal]] surface involvement
*[[Biopsy]] of the primary [[tumor]]
===Fine Needle Aspiration===
===Fine Needle Aspiration===
*[[Fine needle aspiration]] (FNA) for biopsy and histopathological analysis is the optimal method to diagnose nasopharyngeal carcinoma.
*[[Fine needle aspiration]] (FNA) for [[biopsy]] and [[histopathological]] [[analysis]] is used for [[diagnosis]] of nasopharyngeal carcinoma.<ref name="PastorLopez Pousa2017">{{cite journal|last1=Pastor|first1=M.|last2=Lopez Pousa|first2=A.|last3=del Barco|first3=E.|last4=Perez Segura|first4=P.|last5=Astorga|first5=B. Gonzalez|last6=Castelo|first6=B.|last7=Bonfill|first7=T.|last8=Martinez Trufero|first8=J.|last9=Grau|first9=J. Jose|last10=Mesia|first10=R.|title=SEOM clinical guideline in nasopharynx cancer (2017)|journal=Clinical and Translational Oncology|volume=20|issue=1|year=2017|pages=84–88|issn=1699-048X|doi=10.1007/s12094-017-1777-0}}</ref>
*To view microscopic features of nasopharyngeal carcinoma, click [[Nasopharyngeal carcinoma pathophysiology#Microscopic pathology|'''here''']].
*To view [[microscopic]] features of nasopharyngeal carcinoma, click [[Nasopharyngeal carcinoma pathophysiology#Pathology|'''here''']].
 
*


==Immunohistochemistry==
*EBER +ve
*p16 -ve<ref name=pmid9546345>{{cite journal |author=Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J |title=Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product |journal=Am. J. Pathol. |volume=152 |issue=4 |pages=865–9 |year=1998 |month=April |pmid=9546345 |pmc=1858242 |doi= |url=}}</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Disease]]
 
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Medicine]]
[[Category:Oncology]]
[[Category:Otolaryngology]]

Latest revision as of 22:54, 29 July 2020

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma other diagnostic studies

CDC on Nasopharyngeal carcinoma other diagnostic studies

Nasopharyngeal carcinoma other diagnostic studies in the news

Blogs on Nasopharyngeal carcinoma other diagnostic studies

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Nasopharyngoscopy may be helpful in the diagnosis of nasopharyngeal carcinoma. It is used for assessment of tumor extension, determination of mucosal surface involvement and biopsy of the primary tumor. Fine needle aspiration (FNA) for biopsy and histopathological analysis is used for diagnosis of nasopharyngeal carcinoma.

Other Diagnostic Studies

Nasopharyngoscopy

Nasopharyngoscopy may be helpful in the diagnosis of nasopharyngeal carcinoma. It is used for:[1][2][3]

Fine Needle Aspiration

References

  1. Muhyi Al-Sarraf & Maryada S. Reddy (2002). "Nasopharyngeal carcinoma". Current treatment options in oncology. 3 (1): 21–32. PMID 12057084. Unknown parameter |month= ignored (help)
  2. Kamran, Sophia C.; Riaz, Nadeem; Lee, Nancy (2015). "Nasopharyngeal Carcinoma". Surgical Oncology Clinics of North America. 24 (3): 547–561. doi:10.1016/j.soc.2015.03.008. ISSN 1055-3207.
  3. Wei, William I; Sham, Jonathan ST (2005). "Nasopharyngeal carcinoma". The Lancet. 365 (9476): 2041–2054. doi:10.1016/S0140-6736(05)66698-6. ISSN 0140-6736.
  4. Pastor, M.; Lopez Pousa, A.; del Barco, E.; Perez Segura, P.; Astorga, B. Gonzalez; Castelo, B.; Bonfill, T.; Martinez Trufero, J.; Grau, J. Jose; Mesia, R. (2017). "SEOM clinical guideline in nasopharynx cancer (2017)". Clinical and Translational Oncology. 20 (1): 84–88. doi:10.1007/s12094-017-1777-0. ISSN 1699-048X.

Template:WikiDoc Sources